首页> 外文OA文献 >The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial

【2h】

The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial

机译：Siddha医学，Kabasura Kudineer（Ksk）的疗效与维生素C＆ZINC（CZ）补充在无症状Covid-19例中的管理中：随机对照试验的研究方案的结构化概述

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S. Natarajan; C. Anbarasi; P. Sathiyarajeswaran; P. Manickam; S. Geetha; R. Kathiravan; P. Prathiba; M. Pitchiahkumar; P. Parthiban; K. Kanakavalli; P. Balaji;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized controlled trial, Tamil Nadu, India [J] . Natarajan S., Anbarasi C., Sathiyarajeswaran P., Trials . 2021,第1期

机译：与维生素C和锌补充剂相比，Kabasura Kudineer（KSK），在无症状的Covid-19个体中减少了SARS-COV-2病毒载体：从预期，探索性，开放标记，比较，随机的调查结果对照试验，泰米尔纳德邦，印度
2. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol [J] . Marco Marietta, Paola Vandelli, Pasquale Mighali, Trials . 2020,第1期

机译：随机对照试验比较高低低低分子量肝素剂量的疗效和安全性在住院患者严重的Covid-19肺炎和凝血病不需要侵入机械通气（Covid-19 HD）：研究方案的结构化概述
3. Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial [J] . Mary Daval, Alain Corré, Clement Palpacuer, Trials . 2020,第1期

机译：局部预烯丙胺治疗在Covid-19患者持续性脓肿管理中的疗效，没有严重程度：随机对照试验的研究方案的结构化概述
4. A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines Kaba Sura Kudineer (KSK) Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial [O] . Anurag Srivastava, Manickavasagam Rengaraju, Saurabh Srivastava, 2021

机译：一种双盲安慰剂可控的比较临床试验评价Siddha MedicinesKaba Sura Kudineer（KSK）和Nilevembu Kudineer（NVK）以及对症状Covid 19例的标准疗法治疗的标准疗法治疗 - 一种研究方案的结构化概要随机对照试验
5. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial [O] . Keisha Smith, Amy Pace, Stephan Ortiz, 2020

机译：第3阶段开放标签，随机的，受控研究，以评估静脉内给药的Ravulizumab与Covid-19严重肺炎，急性肺损伤或急性呼吸窘迫综合征的最佳支持护理（急性呼吸窘迫综合征）相比的疗效和安全性：A结构化概述用于随机对照试验的研究方案

The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial

著录项

引文网络

相似文献

相关主题

期刊订阅